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WHAT THIS PAPER ADDS
 AortaScan AMI 9700 is a portable 3D ultrasound device that automatically measures the maximum diameter of the abdominal
aorta. It is designed to rapidly diagnose or exclude an AAA andmay have particular use in screening programs. Our objective was to
determine its accuracy to detect AAA. Subjects from our AAA screening and surveillance programs were examined. The aorta was
scanned using the AortaScan and CT. The sensitivity, speciﬁcity, positive and negative predictive values were 81%, 72%, 72% and 81%
respectively. The AortaScan can detect AAA without the need for a trained operator but needs further technical improvement to
increase sensitivity.a r t i c l e i n f o
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Background: AortaScan AMI 9700 is a portable 3D ultrasound device that automatically measures the
maximum diameter of the abdominal aorta without the need for a trained sonographer. It is designed to
rapidly diagnose or exclude an AAA and may have particular use in screening programs. Our objective
was to determine its accuracy to detect AAA.
Methods: Subjects from our AAA screening and surveillance programs were examined. The aorta was
scanned using the AortaScan and computed tomography (CT).
Results: Ninety-one subjects underwent imaging (44 AAA on conventional ultrasound surveillance and 47
controls). The largest measurement obtained by AortaScan was compared against the CT-aortic
measurement. The mean aortic diameter was 2.8 cm. The CT scan conﬁrmed the diagnosis of AAA in 43
subjects. There was one false positive measurement on conventional ultrasound. AortaScan missed the
diagnosis of AAA in eight subjects. There were thirteen false positive measurements. The sensitivity,
speciﬁcity, positive and negative predictive values were 81%, 72%, 72% and 81% respectively.
Conclusion: A device to detect AAA without the need for a trained operator would have potential in
a community-based screening programme. The AortaScan, however, lacks adequate sensitivity and
signiﬁcant technical improvement is necessary before it could be considered a replacement for trained
screening personnel.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
A National Screening Programme for abdominal aortic aneu-
rysm (AAA) is currently being introduced across England to preventx: þ44 20 7928 8742.
altham).
ciety for Vascular Surgery. Publishedeaths from rupture:1e3 Screening scans are usually performed in
the community by a trained technician using a portable ultrasound
scanner.4 The NAAASP (NHS Abdominal Aortic Aneurysm Screening
Programme) will require nearly 500 whole time equivalent
screening technicians to undertake these scans.5 These technicians
are not expected to have prior understanding of aortic anatomy or
experience of ultrasound scanning. A training protocol has been
established for these technicians consisting of formal didacticd by Elsevier Ltd. All rights reserved.
Figure 2. AortaScan screen display once aneurysm is detected.7
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tency assessment.6 It may take up to 6 months training before the
technician is qualiﬁed to scan independently within the
programme.5
The success of the screening programme will critically depend
on not only training the technicians to accurately measure aortic
size but also retaining staff once trained. Early experience with this
model of screening suggests that staff training and retention may
be the greatest challenge faced by the programme.
The use of a portable scanning device that automatically detects
AAAwith a high degree of accuracy would eliminate these training
problems. The AortaScan BVI 9700 (Verathon Medical UK Ltd) is
a portable 3D ultrasound instrument (Fig. 1) that may have this
ability.
The aim of this study was to evaluate the accuracy of the Aor-
taScan BVI 9700 to detect AAA.
Methods
Subjects known to have AAA (based on previous ultrasound, CT
or MR imaging) or a normal aorta (based on screening using
conventional ultrasound) were recruited from our local AAA
screening and surveillance programs from January 2010 to April
2011. AAAwas deﬁned as diameter>3 cm. Subjects with bodymass
index (BMI) >35 kg/m2 were excluded from the study to limit CT
radiation dose. This study is a part of National Institute for Health
Research (NIHR) programme into aortic disease approved by the
local research ethics committee (07/Q0702/62). A short medical
history was taken and BMI was measured on recruitment.
AortaScan
All subjects underwent assessment with the AortaScan AMI
9700 (VerathonMedical UK). This device automatically assesses the
aortic diameter with minimal user skills. Technical details
regarding how the aortic measurements are derived are limited as
they remain the intellectual property of the device manufacturer.
The device uses a 13 mm diameter 3.0 MHz transducer with a ﬁxedFigure 1. AortaScan AMI 9700.7penetration depth of 18 cm. The aorta is detected using differences
in echo-density between the vessel and surrounding tissues, and
the device derives the diameter from themeasured sac volume. The
device measures the inner to inner diameter of the aneurysm sac.
All scans were performed by the same operator (MC) blinded to the
presence of AAA. Prior to the study the operator was trained to use
the device according to the manufacturer advice. This training
consisted of reading a four-page instruction booklet, watching the
onboard video tutorial (4 min) and a 10-min familiarisation session
with a representative from the device manufacturer.
Subjects were scanned supine in a temperature-controlled
relaxed environment. The abdomen was exposed and the scan
performed according to the Instructions For Use.7 The probe is
sequentially placed at four midline positions from the xiphi-
sternum to the umbilicus. Scanning is activated by pressing
a button on the probe and takes less than 3 s at each position. The
aortic size is calculated and a colour LCD screen display indicates
either a normal aorta or the aortic diameter if greater than 3 cm
(Fig. 2). The greatest diameter measured at the four positions was
taken as the value to compare to the true maximum diameterFigure 3. B-mode image on ScanPoint: aneurysm measuring 4.5 cm (V-mode) and
4.2 cm (manual). V-mode technology measures ultrasonic reﬂections on multiple
planes inside the body to produce an image.
Table 1
Subject demographics (abbreviations: BMI, body mass index).
AAA (n ¼ 43) Control (n ¼ 48) P-value
Age (years) 71 (64e81) 66 (65e68) 0.0001
CT-aortic diameter (cm) 3.7 (3e5.5 cm) 2 (1.5e2.9 cm)
BMI (kg/m2) 26.43 26.10 0.647
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a dedicated image management software package (ScanPoint
3.00; Fig. 3) and database.7
CT-scan
All patients underwent aortic CT within 8 weeks of the Aor-
taScan. Non-contrast enhanced images were obtained on a 16-slice
helical scanner with a 3 mm slice thickness (Brilliance CT, Philips,
Eindhoven, Netherlands). Osirix imaging software version 3.9 was
used tomeasure the aorta. Abdominal aortic aneurysmwas deﬁned
as an aorta with an anterioreposterior (inner to inner) diameter
equal or greater than 3 cm.
Statistics
Differences between the control and AAA groups were analysed
using unpaired t-test for continuous data. A P-value less than 0.05
(two sided) was considered signiﬁcant. The data was analysed
using SPSS version 19.0 statistical software (SPSS Inc., Chicago, IL,
USA).
Results
A total of 91 subjects underwent imaging with AortaScan and CT
(mean age 68 years). Forty-three subjects had AAA conﬁrmed by CT
and forty-eight subjects had a normal sized aorta (<3 cm diameter).
The mean CT-aortic diameter was 3.7 cm (range 3e5.5 cm) in AAA
subjects and 2 cm (1.5e2.9 cm) in control subjects. Subject demo-
graphics are shown in Table 1.
The AortaScan correctly detected AAA in 35/43 subjects (sensi-
tivity 81%) with false positives in 13 subjects who did not have AAA
(speciﬁcity 72%). The positive and negative predictive values were
72% and 81% respectively (Table 2).Table 2
Contingency table showing accuracy of AortaScan vs CT-scan. Green represents false pos
                        CT Scan AortaScan
 BVI 9700
AAA (yes) AAA (no) 
AAA (yes) 35  13  
AAA (no) 8  35  
 Sensitivity 
81%
Specificity
72%The aneurysms missed by the AortaScan ranged from to 3.6 cm
to 4.4 cm in size (mean 3.85 cm). We analysed the possible effect of
body mass index (BMI) on AortaScan results for patients with BMI
35 kg/m2. The average BMI of subjects included in the study was
26.1 kg/m2 (15.5e35 kg/m2). A comparison of BMI between
different groups did not show any signiﬁcant effect of abnormal
BMI on AortaScan accuracy (Fig. 4) and chi2 test for normal BMI
(18.5e25 kg/m2) vs abnormal BMI (<18.5 or >25 kg/m2) P ¼ 0.157).Discussion
Consensus exists across guidelines on one-time screening of
elderly men to detect and treat AAAs 5.5 cm.8 Screening for any
disease requires a test that is accurate, easily available and cost-
effective. In this study we have compared accuracy of the AortaS-
can AMI 9700 to detect AAA in subjects with normally sized aortas
and patients with small AAA. We have compared the results given
by the device with aortic size assessed by CT. The availability of an
automatic device to accurately detect AAAwith minimum operator
training could greatly increase the chance of delivering a compre-
hensive and effective screening programme.
The AortaScan is an automated ultrasound device designed to
detect the presence of an AAA. The purpose of this study was to
assess whether the AortaScanwould have a role within a screening
programme for AAA. Cost-effective screening programmes will
need to utilise relatively inexperienced scanning technicians rather
than trained sonographers. We have therefore compared the Aor-
taScan ﬁndings against CT rather than compare to conventional
ultrasound to determine its true accuracy. Of note themanufacturer
states that it is not designed to accurately measure the diameter of
the aorta but is simply aimed at detecting whether the maximum
diameter is 3 cm or greater.
Current recommendations are that four positions are scanned in
the midline from the xiphisternum to the umbilicus; this is inten-
ded to decrease the false negative rate. At present the device will
indicate that either the aorta is normal (i.e.<3 cm diameter) or will
indicate an estimated aortic size if >3 cm diameter. The manufac-
turers of the device do not claim this to be an accurate sizing; the
purpose of the AortaScan is for screening rather than surveillance.
We believe it is therefore confusing and misleading that the device
has been designed to display a value for size. As no accurate size is
calculated, patients with detected small aneurysms would need toitive results and orange shows false negative results in the below table.
 
Positive predictive value 72%  
Negative predictive value 
81%
 
Figure 4. Comparison of body mass index (BMI  35 kg/m2) between different groups
did not show any effect of BMI on AortaScan results.
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measurements. Future developments of the device may overcome
this limitation.
Trials demonstrating the efﬁcacy of AAA screening have used
trained sonographers to screen a limited population.9,10 The
number of scans, however, required in a national programme far
exceed the capacity available for sonographers to perform, and so
the model adopted by the NAAASP relies on training personnel
previously unskilled in ultrasound to perform the screening scans.
Although conventional ultrasound can achieve a very high sensi-
tivity and speciﬁcity this requires a prolonged training programme
to achieve a minimum level of operator ability. There are concerns
that in practice it may be difﬁcult to achieve a consistent level of
quality from inexperienced scanning personnel. An additional
challenge is tomaintain staff retention after training. An automated
ultrasound scanner to detect AAAwould eliminate these problems.
One previous study has been reported assessing the accuracy of
the previous AortaScan model against conventional ultrasound
rather than CT.11 A 90% sensitivity and 94% speciﬁcity to detect AAA
was reported with the AortaScan device but the conventional
ultrasound also suffered from a number of false positives and false
negatives, rendering the results difﬁcult to interpret. Little infor-
mation was reported regarding factors that affected false results.
One possible explanation for a greater sensitivity in this study is
that the mean aortic diameter was larger than in ours (3.9 cm vs
2.8 cm).
In our study we have compared the device against CT imaging,
the most accurate assessment of true anatomy, and have found
a lower sensitivity of 81%. This level of sensitivity of the device in its
current form would not be adequate for its use in a screening
programme. Factors that affect accuracy may include patient
morphology, vessel tortuosity and the presence of thrombus within
the sac. Although we found no statistically signiﬁcant relationship
between incorrect results and BMI in these patients there was
a trend towards a greater BMI in those subjects with false negative
results (shown in Fig. 4). Patients with BMI >35 kg/m2 were
excluded from the study to limit radiation dose; it is possible that
the accuracy of the device would be worse if these patients were
included. No patients in this study had severe tortuosity, and as the
CT scans were performed without contrast we were unable to
analyse whether thrombus had any effect on accuracy. In this study
we have conﬁned testing to patients with small (i.e. <5.5 cmdiameter) AAA. These would make up the majority of AAA detected
in the screening programme.9 It could be anticipated that for larger
AAA the device would be more sensitive; we are currently testing
this hypothesis.
Evidence is emerging that patients with dilated aortas that do
not currently meet the deﬁnition of AAA (i.e. measuring 2e3 cm in
diameter) may also dilate over time and eventually be at risk of
rupture.12 These patients may in future be included on surveillance
programmes and so devices such as AortaScan will need to also be
able to accurately detect these small diameter aortas.
Conclusion
The AortaScan is a portable and easy to use ultrasound device
requiring minimal training but in its current form does not have
adequate sensitivity to be considered for the National Screening
Programme. It requires substantial further technical development
before it could be considered as a screening device for AAA in place
of conventional ultrasound.
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